✦ LIBER ✦

Impact of adalimumab treatment on patient‐reported outcomes: Results from a Phase III clinical trial in patients with moderate to severe plaque psoriasis

✍ Scribed by Revicki, Dennis A.; Willian, Mary Kaye; Menter, Alan; Gordon, Kenneth B.; Kimball, Alexa B.; Leonardi, Craig L.; Langley, Richard G.; Kimel, Miriam; Okun, Martin

Book ID: 125518218
Publisher: Informa plc
Year: 2007
Tongue: English
Weight: 236 KB
Volume: 18
Category: Article
ISSN: 0954-6634
DOI: 10.1080/09546630701646172

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of efalizumab on patient-reported

Impact of efalizumab on patient-reported outcomes in patients with moderate to severe plaque psoriasis: pooled results from three randomized phase III trials

✍ Alan Menter; Tiffani Hamilton; Ivor Caro; Amy Chen-Rundle 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Impact of adalimumab treatment on health

Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasis

✍ D. Revicki; M.K. Willian; J.-H. Saurat; K.A. Papp; J.-P. Ortonne; C. Sexton; A. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB

The benefits of adalimumab on clinical a

The benefits of adalimumab on clinical and patient-reported outcomes among moderate to severe psoriasis patients with comorbidities

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Ustekinumab treatment in patients with m

Ustekinumab treatment in patients with moderate to severe psoriasis who are nonresponders to etanercept: Results from a phase III clinical trial

📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 49 KB

CLinical Experience Acquired with Raptiv

CLinical Experience Acquired with Raptiva® (CLEAR) trial in patients with moderate-to-severe plaque psoriasis: results from extended treatment in an international, Phase III, placebo-controlled trial

✍ Wolfram Sterry; Georg Stingl; Richard G.B. Langley; Hugh Zacharie; Morad Lahfa; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 German ⚖ 316 KB

Adalimumab in Japanese patients with mod

Adalimumab in Japanese patients with moderate to severe chronic plaque psoriasis: Efficacy and safety results from a Phase II/III randomized controlled study

✍ Akihiko ASAHINA; Hidemi NAKAGAWA; Takafumi ETOH; Mamitaro OHTSUKI; THE ADALIMUMA 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 490 KB